{"Abstract": [0], "Studies": [1], "in": [2, 35, 46, 71, 83, 102, 132, 154, 189, 211, 215], "neurodegenerative": [3, 144, 193, 222], "diseases,": [4, 145, 194], "including": [5, 195], "Alzheimer\u2019s": [6, 196], "disease,": [7, 15, 197, 199], "Parkinson\u2019s": [8, 198], "disease": [9], "and": [10, 16, 56, 90, 146, 182, 200, 214], "Amyotrophic": [11, 201], "lateral": [12, 202], "sclerosis,": [13], "Huntington\u2019s": [14], "so": [17], "on,": [18], "have": [19, 96, 150, 166], "suggested": [20, 98], "that": [21], "inflammation": [22, 59], "is": [23], "not": [24], "only": [25], "a": [26, 32, 91], "result": [27], "of": [28, 93, 105, 121, 143, 148, 161, 192, 221], "neurodegeneration": [29, 47, 133], "but": [30], "also": [31, 205], "crucial": [33], "player": [34], "this": [36], "process.": [37], "Protein": [38], "aggregates": [39], "which": [40, 51], "are": [41, 109, 134], "very": [42, 164], "common": [43], "pathological": [44], "phenomenon": [45], "can": [48], "induce": [49, 80], "neuroinflammation": [50, 181], "further": [52], "aggravates": [53], "protein": [54, 64, 81], "aggregation": [55], "neurodegeneration.": [57], "Actually,": [58], "even": [60], "happens": [61], "earlier": [62], "than": [63], "aggregation.": [65], "Neuroinflammation": [66], "induced": [67], "by": [68, 75, 169], "genetic": [69], "variations": [70], "CNS": [72, 94], "cells": [73, 78, 95], "or": [74, 126, 157], "peripheral": [76], "immune": [77], "may": [79], "deposition": [82], "some": [84], "susceptible": [85], "population.": [86], "Numerous": [87], "signaling": [88, 129, 186], "pathways": [89, 130, 187], "range": [92], "been": [97, 167], "to": [99, 117, 136], "be": [100, 137], "involved": [101, 131, 188], "the": [103, 118, 141, 178, 183, 190, 207, 216, 219], "pathogenesis": [104], "neurodegeneration,": [106], "although": [107, 163], "they": [108], "still": [110], "far": [111], "from": [112], "being": [113], "completely": [114], "understood.": [115], "Due": [116], "limited": [119], "success": [120], "traditional": [122], "treatment": [123, 220], "methods,": [124], "blocking": [125], "enhancing": [127], "inflammatory": [128, 185], "considered": [135], "promising": [138], "strategies": [139], "for": [140, 171, 218], "therapy": [142], "many": [147], "them": [149], "got": [151], "exciting": [152], "results": [153], "animal": [155, 212], "models": [156, 213], "clinical": [158, 172], "trials.": [159], "Some": [160], "them,": [162], "few,": [165], "approved": [168], "FDA": [170], "usage.": [173], "Here": [174], "we": [175], "comprehensively": [176], "review": [177], "factors": [179], "affecting": [180], "major": [184], "pathogenicity": [191], "sclerosis.": [203], "We": [204], "summarize": [206], "current": [208], "strategies,": [209], "both": [210], "clinic,": [217], "diseases.": [223]}